The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAT-1 Inside Vascular Endothelial Cells With and Without LPS Challenge

Karabiyik A., YILMAZ E., Gulec S., Haznedaroglu I., Akar N.

TURKISH JOURNAL OF HEMATOLOGY, cilt.29, sa.4, ss.361-366, 2012 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 4
  • Basım Tarihi: 2012
  • Doi Numarası: 10.5505/tjh.2012.90277
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.361-366
  • Anahtar Kelimeler: Ankaferd, EPCR, PAI-1, LPS, HUVEC, PROTEIN-C RECEPTOR, PLASMINOGEN-ACTIVATOR INHIBITOR-1, IN-VITRO, INSERTION MUTATION, MANAGEMENT, AGENT, EFFICACY, CANCER
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Ankaferd blood stopper (ABS) is comprised of a mixture of the plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica. ABS is used as a topical hemostatic agent due to its antihemorrhagic effect, yet its hemostatic mechanism of action remains to be investigated. ABS does not affect the levels of coagulation factors II, V, VII, VIII, IX, X, XI and XII. The aim of this study was to investigate the effects of ABS on endothelium and immune response. As such, we evaluated changes in endothelial cell protein C receptor (EPCR) and plasminogen activator inhibitor type-1 (PAI-1) expression inside human umbilical vein endothelial cells (HUVECs) in the presence and absence of lipopolysaccharides (LPSs). Material and